MedPath

Ergotamine

Generic Name
Ergotamine
Brand Names
Ergomar, Migergot
Drug Type
Small Molecule
Chemical Formula
C33H35N5O5
CAS Number
113-15-5
Unique Ingredient Identifier
PR834Q503T

Overview

A vasoconstrictor found in ergot of Central Europe. It is an alpha-1 selective adrenergic agonist and is commonly used in the treatment of migraine disorders.

Background

A vasoconstrictor found in ergot of Central Europe. It is an alpha-1 selective adrenergic agonist and is commonly used in the treatment of migraine disorders.

Indication

For use as therapy to abort or prevent vascular headache, e.g., migraine, migraine variants, or so called "histaminic cephalalgia".

Associated Conditions

  • Cluster Headache
  • Migraine
  • Uterine Atony
  • Vascular Headaches

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor

No clinical trials found

No clinical trials found for this drug

FDA Approved Products

Product Name
Manufacturer
Route
Strength
Approved
NDC Code
ORAL
1 mg in 1 1
2021/12/21
24470-917
ORAL
2 mg in 1 1
2016/12/01
70720-120
SUBLINGUAL
2 mg in 1 1
2012/09/08
10802-1202
RECTAL
2 mg in 1 1
2022/11/29
0713-0166

EMA Approved Products

Medicine Name
EMA Number
Auth. Holder
Country
Drug Type
Status
Issued
Opinion
Revision

No EMA products found

No EMA products found for this drug

HSA Approved Products

Product Name
Manufacturer
Dosage Form
Strength
Approved
Approval No.
TABLET
1 mg
2001/12/26
SIN11746P

NMPA Approved Products

Product Name
Approval No.
Manufacturer
Dosage Form
Trade Name
Strength
Type
Status
Date
Import

No NMPA products found

No NMPA products found for this drug

PPB Approved Products

Product Name
Registration Code
Company
Category
Sale Type
Reg. Date

No PPB products found

No PPB products found for this drug

TGA Approved Products

Product Name
ARTG ID
Sponsor
Status
Reg. Date
Ingredient

No TGA products found

No TGA products found for this drug

© Copyright 2025. All Rights Reserved by MedPath